Abiopharma

🔍 Cole Matthew Ryan (Director)

Company: Strive, Inc. (ASST)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 280,112 shares of Performance Stock Unit (Derivative)
  Date: 2026-08-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 280,112.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F1, F1

Footnotes:

• F1: Each performance stock unit ("PSU") represents a contingent right to receive one share of Class A common stock of the issuer if predetermined levels of total shareholder return relative to the return of Bitcoin, as well as the Russell 3000 over the three-year performance period from January 1, 2026 through December 31, 2028. The number of PSUs represents a target number and the reporting person may earn between 0% and 200% of the target number of PSUs.